Boca Raton, FL -- (SBWIRE) -- 10/21/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks - Knightsbridge Tankers Limited (NASDAQ:VLCCF), Immunomedics, Inc. (NASDAQ:IMMU), Align Technology, Inc. (NASDAQ:ALGN), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
Knightsbridge Tankers Limited (NASDAQ:VLCCF) ended lower -17.21% and complete the day at $8.61. The total number of shares changed hands during the day was 3.76 million. After opening at $8.79, the stock hit as high as $8.85. However, it traded between $4.94 and $10.69 over the last twelve months. Knightsbridge Tankers Limited, a shipping company, engages in the seaborne transportation of crude oil and dry bulk cargoes worldwide. As of December 31, 2012, it owned and operated one very large crude carrier and four Capesize dry bulk carriers.
Has VLCCF Found The Bottom and Ready To Move Up? Find Out Here
Immunomedics, Inc. (NASDAQ:IMMU) closed yesterday at $4.47, a -11.56% decrease. Around 3.12 million shares were traded, beating an-average trading volume of 1.20 million shares. The company is now valued at around $371.14 million. Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases.
Has IMMU Found The Bottom And Ready To Gain Momentum? Find Out Here
Align Technology, Inc. (NASDAQ:ALGN) moved +26.24 percent higher at $57.98 and traded between $53.15 and $60.00 after opening the day at $53.20. Its performance over the last five days remained +33.75%, which stands at +21.83% for a month. Going back further than one month, 1-year performance after recent close was +108.94%. Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. It designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services that are used in dentistry, orthodontics, and dental records storage.
For How Long ALGN’s Gloss will Attract Investors? Find out via this report
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)’s shares dropped, -17.58 percent to close at $7.83. The stock is up around +111.62% this year and +109.92% for the last 12 months. Around 2.33 million shares changed hands yesterday, higher from an-average trading volume of 641,205 shares. Vanda Pharmaceuticals, Inc., a biopharmaceutical company, offers development and commercialization of products for the treatment of central nervous system disorders. The company provides Fanapt, a compound for the treatment of schizophrenia; and VLY-686, a small molecule neurokinin-1 receptor (NK-1R) antagonist that has indications for chemotherapy-induced nausea and vomiting.
Will VNDA Get Buyers Even After The Recent Rally? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)